Medical polymers is the term used for the building blocks of most medical devices today. These polymers include a large range of functional components such as elastomeric fibers, polyethylene glycol, plastics, rubber micro particles, polyethylene Teflon, rubber powder, resins, and thermoform, silicone, nylon, cement, and rubber composites. Medical polymers are generally classified into synthetic resins, synthetic fibers, and elastomeric fibers. Medical polymers can be used as fillers and additives in a variety of medical plastics, packaging, and devices. They are also used in the manufacturing of surgical gloves and other medical accessories. Some of the most common Medical Polymers include neoprene, polystyrene, polyurethane, polyisocyanurate, polycarbonate, acrylate, polyethylene terephthalate (PET), and polycarbonate plastic.

Market Dynamics

The growing prevalence of chronic disease and increasing investment in healthcare are driving the growth of the Global medical polymer market. Increasing use of advanced medical technologies such as 3D printed implants and customized devices are again fostering the growth of the market. Moreover, the continuous launch of innovative products by key players will further favor the growth of the market. For instance, in February 2020, Clariant announced the launch of a medical polymer compound resistant to hydrolytic degradation caused by exposure to high humidity and temperature.

On the other hand, strict rules & regulation regarding the usage of polymer is hampering the growth of the market.

Key features of the study:

• This report provides in-depth analysis of the medical polymers market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global medical polymers market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include BASF SE, Bayer MaterialScience AG, Celanese Corporation, DSM N.V., E. I. du Pont de Nemours Company, Eastman Chemical Company, ExxonMobil Corporation, Evonik Industries AG, and The Dow Chemical Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global medical polymers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical polymers market

Detailed Segmentation:

• Global Medical polymers Market, By Product Type:
  • Fibers and resin
    • PVC
    • PP
    • PE
    • PS
    • Others (engineering thermoplastics such as nylon, PET, PA, PC, ABS)
  • Medical Elastomers
    • Styrenic Block Copolymer
    • Rubber latex (NR + Butyl Rubber + Silicone rubber)
    • Others (TPU, TPO, TPV)
  • Biodegradable plastic
• Global Medical polymers Market, By Applications
  • Medical devices and equipment’s
  • Medical packaging
  • Others (cardio, tissue culture)
• Global Medical polymers  Market, By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles
  • BASF SE
  • Bayer MaterialScience AG
  • Celanese Corporation
  • DSM N.V.
  • I. du Pont de Nemours Company
  • Eastman Chemical Company
  • ExxonMobil Corporation
  • Evonik Industries AG
  • The Dow Chemical Company